GSK-113173

Study Sponsor: GSK

Study Title

Study of GSK2302025A Antigen-Specific Cancer Immunotherapeutic in patients with metastatic melanoma

Medicine or Vaccine (generic name)

GSK2302025A

Sponsor Identification Number

113173

Trial Registry Identification Number(#'s)

NCT01149343 2009-016636-13

Medical Condition

Melanoma

Phase

Phase 1

Link to study details on the GSK Clinical Study Register

Link to study details on ClinicalTrials.gov (if available)

Link to study details on EudraCT (if available)

Datasets and Documents Available for this Study

Raw dataset	Annotated case report form	Dataset specifications	Protocol with any amendments
Analysis-ready dataset	Reporting and analysis plan	Clinical study report	Ready to Share

Additional information about the data and documents available for this study

Date Added to this Site

February 2018